info@seagull-health.com
SeagullHealth
语言:
search

Levodopa(Inbruja)

Names
carbidopa,RYTARY,卡比多巴,左旋多巴吸入粉剂
Indicatons
VYALEV injection is indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease.
Price:
Manufacturer:
Acorda Therapeutics, Inc.
Dosage form:
INJECTION
Validity period:
24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Inbruja(Levodopa) Instructions:Uses,Dosage, Side Effects

VYALEV™ is a combination injectable medication consisting of foscarbidopa (an aromatic amino acid decarboxylation inhibitor) and foslevodopa (an aromatic amino acid), which is designed to provide continuous dopaminergic stimulation through subcutaneous administration. The drug is administered via a specialized infusion pump (VYAFUSER), typically in the abdominal region, allowing for precise control over the delivery of the medication. It is used to address motor fluctuations in patients with advanced Parkinson's disease who require more consistent dopaminergic therapy to manage the progressive symptoms of their condition.

VYALEV is a highly effective treatment for managing "off" episodes and motor control in Parkinson’s disease patients. It combines the benefits of foscarbidopa and foslevodopa, ensuring that levodopa is optimally available to the brain while minimizing peripheral conversion and side effects. As a subcutaneous infusion, it offers patients an alternative to oral medication regimens, ensuring more stable blood levels of levodopa, which can lead to a reduction in motor fluctuations. This method of delivery is particularly useful for those with advanced disease and significant daily motor disability.

Generic name
Levodopa(Inbruja)
English name
Levodopa
Alternative Names
carbidopa,RYTARY,卡比多巴,左旋多巴吸入粉剂
Drug prices
Indications

VYALEV™ is indicated for the treatment of motor fluctuations in adults with advanced Parkinson's disease. Specifically, it is used to manage "off" periods and enhance the motor control for individuals who experience inconsistent movement control as part of the disease progression.

Therapeutic Target
The therapeutic target of VYALEV™ is the improvement of motor symptoms in patients with advanced Parkinson’s disease, particularly addressing motor fluctuations related to "off" periods.
Active Ingredients
Foscarbidopa
Dosage Form
INJECTION
Specifications
Available in vials containing 120 mg of foscarbidopa and 2,400 mg of foslevodopa per 10 mL.
Dosage and Administration

Administration Route: Subcutaneous injection.

Preferred Injection Site: The abdomen is the recommended site for injection.

Administration Device: The VYAFUSER pump is used to administer VYALEV™.

Dosage Calculation: Dosage should be individualized for each patient. The full prescribing information provides detailed instructions on the calculation of base continuous dosage, hourly infusion rates, and adjustments such as loading doses or extra doses based on patient response.

Maximum Recommended Daily Dosage: 3,525 mg of foslevodopa (approximately equivalent to 2,500 mg levodopa) per day.

    Recommended articles
    Related articles
    Can Levodopa Inhalation Powder Be Covered by Medical Insurance?
    Levodopa inhalation powder is a novel formulation for the treatment of Parkinson's disease. Patients primarily focus on its medical insurance reimbursement status, correct usage methods, and poten...
    How Much Does Levodopa Inhalation Powder Cost?
    Levodopa Inhalation Powder, also known by aliases such as Inbrija, carbidopa, and RYTARY, is an innovative drug for patients with Parkinson's disease. Currently, it has not been launched in China ...
    Price Overview of Levodopa Inhalation Powder in 2025
    Levodopa Inhalation Powder, with the English name levodopa, is an innovative treatment option for "off" episodes in patients with Parkinson's disease. Its price, purchasing methods, and ...
    What is the Dosage and Administration of Levodopa Inhalation Powder?
    Inbrija (levodopa inhalation powder) is an inhalable rescue medication specifically designed for patients with Parkinson's disease. The standard dose is two 42mg capsules (a total of 84mg) per inh...
    What Are the Precautions for Using Levodopa Inhalation Powder?
    The original research and development company of Levodopa Inhalation Powder is Acorda Therapeutics. It is an intermittent treatment drug for the "off" - phase symptoms of Parkinson's dis...
    How Effective is Levodopa Inhalation Powder in Treatment?
    Levodopa Inhalation Powder, with the English name levodopa, is an emergency medication for the "off" - phase symptoms of Parkinson's disease. Through the mechanism of rapid absorption vi...
    New Drugs
    Infigratinib(Truseltiq)
    Infigratinib(Truseltiq)
    Treatment of previously treated, unresectable locally advanced or metastatic...
    Opicapone(Ongentys)
    Opicapone(Ongentys)
    Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
    Deflazacort(Emflaza)
    Deflazacort(Emflaza)
    Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
    Faricimab-svoa(Vabysmo)
    Faricimab-svoa(Vabysmo)
    Treatment of neovascular age-related macular degeneration, diabetic macular...
    Counselling Service
    Global Drug Search
    Clinical Research Recruitment
    Overseas Medical Treatment
    Remote Consultations
    Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
    Submit
    Business
    • Core products
    • Antitumor drugs
    • General drug
    • Antiviral drugs
    • Biological agents
    Contact Us 
    • mailbox:info@lucius.la
    Welcome to consult
    ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved